Eli Lilly’s therapy with solanezumab didn’t decelerate the illness
Eli Lilli on Wednesday said it would halt development of its Alzheimer's treatment candidate solanezumab after the antibody failed to slow the progression…
Jim Faile has done it all in his 27 year as an Author, Editor, Writer, Copywriter, Blogger, and Mentor. You name a newsroom beat and Jim has covered it with the best of them. He also loves his dogs, traveling, Rays baseball, and dreaming up his next writing project.
Recover your password.
A password will be e-mailed to you.